Lavallée and colleagues [238], using an in vivo xenograft model, found that promyelocytic leukemia cells expressing podoplanin induced thrombocytopenia and prolonged bleeding time, while none of these effects were observed with podoplanin-negative leukemia cells. This evidence concerns the gene PDPN and leukemia.